市場調査レポート

商品コード

1800768

プロテオミクスの市場レポート：分析タイプ別、コンポーネントタイプ別、技術別、用途別、エンドユーザー別、地域別、2025～2033年

Proteomics Market Report by Analysis Type, Component Type, Technology, Application, End-User (Clinical Diagnostic Laboratories, Research Organizations, and Others), and Region 2025-2033

出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 447,600円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペースト、印刷はできません。

PDF & Excel (5 User License)

USD 3,999 596,850円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストはできませんが、印刷は5部まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 746,100円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストは可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.25円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のプロテオミクスの市場規模は2024年に415億米ドルに達しました。今後、IMARC Groupは、2033年には1,394億米ドルに達し、2025～2033年にかけて13.68%の成長率（CAGR）を示すと予測しています。北米は現在、強固な研究インフラと製薬・バイオテクノロジー企業の強力なプレゼンスが市場を独占しています。同市場は主に、質量分析における急速な技術進歩、慢性疾患の増加、個別化医薬品への急速なシフトによって牽引されています。さらに、機械学習（ML）と人工知能（AI）の統合が進み、タンパク質解析とデータ解釈の高度化が進んでいます。

主要セグメント

分析タイプ：構造プロテオミクス、機能プロテオミクス、タンパク質発現プロテオミクスに区分されます。
コンポーネントタイプ：コアプロテオミクスサービスとバイオインフォマティクスソフトウェアおよび関連サービスに二分されます。
技術：タンパク質マイクロアレイは、タンパク質の相互作用、発現、機能を迅速かつ大規模に解析できるため、市場をリードしています。ハイスループットであるため、バイオマーカー探索や疾病診断に理想的です。
用途：タンパク質発現プロファイリング、プロテオームマイニング、翻訳後修飾に分類されます。
エンドユーザー：研究機関（創薬）は、バイオマーカー同定と疾患メカニズム研究に重点を置いているため、最大の市場シェアを占めています。研究開発（R&D）活動を加速させるため、先進的プロテオミクス技術に多額の投資を行っています。
地域：北米は研究開発への投資が高く、バイオテクノロジー企業や製薬企業が多く存在するため、プロテオミクス市場をリードしています。政府の支援、先進ヘルスケアシステム、革新的技術の早期導入が、同地域の市場牽引力をさらに高めています。

主要プレイヤー

プロテオミクス市場の主要企業には、Agilent Technologies Inc.、Bio-RAD Laboratories Inc.、Bruker Corporation、Creative Proteomics、Danaher Corporation、GE Healthcare Inc.、Horiba Ltd.、Luminex Corporation、Merck Group、Perkinelmer Inc.、Promega Corporation、Thermo Fisher Scientific Inc.、Waters Corporationなどがあります。

主な市場促進要因

個別化医療への需要の高まり：個別化医療へのアプローチは、臨床および製薬現場におけるプロテオミクスツールの採用を促進します。プロテオミクスは特定のバイオマーカーを特定し、標的薬剤の開発をサポートし、治療成果を向上させます。
がん研究への注目の高まり：タンパク質は腫瘍の生物学、進行、薬剤耐性において重要な役割を果たしています。プロテオミクス解析は、がん特異的バイオマーカーの同定、早期診断のサポート、標的治療の指針となります。このような研究需要により、腫瘍学研究全体でプロテオミクス技術への投資が活発化しています。
学術機関とバイオテクノロジー企業間の提携：パートナーシップにより、プロテオミクスツール、診断ソリューション、治療薬の迅速な開発が促進されています。共同研究はまた、より多くの資金を集め、研究能力を拡大し、商業化パイプラインを強化します。
シングルセルプロテオミクスの台頭：シングルセルプロテオミクスの開発により、研究者は個々の細胞レベルでのタンパク質発現を研究できるようになりました。この技術革新により、細胞の多様性や希少な集団が明らかになり、疾患理解や創薬ターゲティングが強化されます。
次世代シーケンサー（NGS）の技術的進歩：次世代シーケンサーの進歩は、マルチオミクスアプローチを可能にします。NGSデータはタンパク質発現研究にゲノム的背景を提供し、バイオマーカー探索と精密医療を向上させます。

将来の展望

力強い成長展望：プロテオミクス市場は、個別化医療に対する高い需要と質量分析およびバイオインフォマティクスの革新により、持続的な拡大が見込まれます。創薬やバイオマーカー同定における継続的な研究が市場拡大をさらに後押ししています。
市場の進化：この分野は、基本的なタンパク質解析から、タンパク質マイクロアレイやバイオインフォマティクスツールのような高度な技術へと移行していくと予想されます。より的を絞ったデータベースの生物学的研究へのシフトを反映し、診断や個別化医療において重要な役割を果たしています。

プロテオミクス市場は、細胞の不均一性に対する深い洞察を提供し、より正確な疾患モデリングと治療ターゲティングを可能にするシングルセルプロテオミクスの台頭により拡大しています。学術機関とバイオテクノロジー企業の協働がイノベーションを加速し、研究を実用的な診断・治療ソリューションに迅速に変換することを可能にしています。質量分析、タンパク質マイクロアレイ、NGSの技術的進歩により、データの精度、スループット、コスト効率も向上しています。プロテオミクス装置の自動化と小型化が進み、効率が向上し、サンプル量が減少し、運用コストが低下しています。さらに、プロテオミクスとゲノミクスやメタボロミクスのような他のオミクスプラットフォームとの統合により、包括的な生物学的分析が可能になり、その応用範囲はさらに広がっています。政府の資金援助、バイオマーカー探索に対する規制当局の支援、農業や環境モニタリングにおけるプロテオミクスの利用拡大も、市場の成長に寄与しています。

プロテオミクス市場の動向

慢性疾患および感染症の罹患率の増加

慢性疾患や感染症の罹患率の高さが市場の成長を大きく後押ししています。がん、糖尿病、心血管障害、感染症などの疾患が蔓延しているため、分子レベルで疾患メカニズムを理解する必要性が高まっています。NIHによると、2024年には米国で新たに200万1,140のがん症例が発生すると予測されていました。プロテオミクスは、研究者や臨床医が疾患特異的バイオマーカーを同定し、疾患の進行をモニターし、標的療法を開発することを可能にします。また、慢性疾患を効果的に管理する上で重要な早期診断にも役立ちます。個別化医療や精密治療の需要は、タンパク質の相互作用や機能をより深く分析できるプロテオミクスツールの使用をさらに促進しています。

医薬品研究開発活動の増加

医薬品研究開発活動の活発化は、市場にプラスの影響を与えています。Swiss Biotech Report 2025に記載されているように、スイスの研究開発費は2024年には26億スイスフラン（31億6,000万米ドル）に達し、民間会社が14億スイスフランを拠出しています。製薬会社が創薬と開発に注力する中、タンパク質の構造、機能、相互作用に関する洞察を提供できる高度なツールに対する需要が高まっています。プロテオミクスは、研究者が潜在的な創薬標的を同定・検証し、疾患経路を理解し、分子レベルで薬効や毒性を評価することを可能にします。標的治療薬の開発に重点が置かれる中、プロテオミクスは疾患特異的なバイオマーカーを検出し、それに応じて治療を調整するために不可欠なものとなりつつあります。さらに、生物製剤やバイオシミラーの採用により、精密なタンパク質分析の必要性がさらに高まっています。

AI採用の増加

AI導入の増加は、データ分析を合理化し、パターン認識を向上させ、バイオマーカー発見を加速させています。IMARC Groupによると、世界のAI市場規模は2024年に1,156億2,000万米ドルとなりました。プロテオミクスは、正確な解釈のために高度な計算ツールを必要とする巨大で複雑なデータセットを生成します。AIアルゴリズム、特にMLは、特定の疾患に関連する微妙なタンパク質発現パターンを特定するのに役立ち、より迅速で正確な診断や医薬品開発を可能にします。AIはまた、プロテオミクスデータを他の生物学的データセットと統合することで、個別化医療における予測モデリングを強化します。このような技術的相乗効果により、学術研究と製薬研究の両方において、研究期間が短縮され、効率が向上します。さらに、AIを活用した自動化により、人為的ミスが最小限に抑えられ、運用コストが削減されます。組織がAIをプロテオミクスのワークフローに組み込むことで、病気の発見と治療におけるイノベーションは急速に進み続けています。プロテオミクス市場レポートによると、この技術動向は業界の将来を形作る上で重要な役割を果たしています。

プロテオミクス市場の主な成長要因

学術機関とバイオテクノロジー企業の提携

学術機関とバイオテクノロジー企業間の提携の増加は、研究イノベーションと商業的実行を組み合わせることによって、プロテオミクス市場の成長を大きく後押ししています。学術機関は深い科学的知識と最先端の発見を提供し、バイオテクノロジー企業はこれらの発見を市場に通用する用途に変換するためのリソース、インフラ、専門知識を提供します。このようなパートナーシップは、新規プロテオミクス技術、診断ツール、治療薬の開発を加速させます。ジョイントベンチャーは、基礎研究と現実の臨床ニーズとのギャップを埋め、イノベーションサイクルの迅速化につながります。このような共同研究は、官民双方から資金を集めることが多く、大規模なプロテオミクス研究や高度なバイオマーカー同定を可能にしています。人材、機器、データベースへのアクセスを共有することで、研究成果と商業的可能性がさらに強化されています。

シングルセルプロテオミクスの出現

シングルセルプロテオミクスの出現により、研究者は個々の細胞レベルでタンパク質を分析できるようになり、細胞の不均一性や疾患メカニズムに関する洞察を得ることができます。多数の細胞からのシグナルを平均化するバルク解析とは異なり、シングルセル技術は各細胞のユニークなプロテオミクスプロファイルを捉え、細胞の挙動、免疫応答、がんの進行をより深く理解することを可能にします。このレベルの粒度は、疾患に関与する希少な細胞タイプや亜集団の同定に役立つため、個別化医療の開発には極めて重要です。高分解能質量分析計とマイクロ流体プラットフォームの利用拡大により、シングルセルプロテオミクスはより実現可能でスケーラブルになりました。研究者や製薬会社がこのアプローチを採用するにつれて、バイオマーカー探索や治療ターゲットに新たな道が開かれつつあります。

NGSの技術的進歩

NGSの技術的進歩は、マルチオミクスの統合を強化し、生物学的洞察の深さを拡大しています。NGSは主にゲノムおよびトランスクリプトーム解析に用いられますが、プロテオミクスとの相乗効果により、細胞機能のより完全な理解が可能になります。研究者は遺伝子発現データをタンパク質発現や修飾と関連付けることができ、バイオマーカー同定や疾患モデリングの改善につながります。シングルセルシーケンスや空間トランスクリプトミクスなどの技術革新により、組織内の遺伝子やタンパク質ネットワークの高解像度マッピングが可能になりつつあります。これらの技術により、ゲノム情報に基づいたプロテオミクス実験の設計が容易になり、精度と関連性が向上しています。NGSが広く利用できるようになったことで、データ駆動型の研究戦略も促進され、補完的なプロテオミクスツールの需要も高まっています。NGSプラットフォームが進化するにつれ、プロテオミクス市場のアプリケーションをサポートし、拡大し続けています。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ

第12章 SWOT分析

第13章バリューチェーン分析

第14章ポーターのファイブフォース分析

第15章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Agilent Technologies Inc.
- Bio-RAD Laboratories Inc.
- Bruker Corporation
- Creative Proteomics
- Danaher Corporation
- GE Healthcare Inc.
- Horiba Ltd.
- Luminex Corporation
- Merck Group
- Perkinelmer Inc.
- Promega Corporation
- Thermo Fisher Scientific Inc.
- Waters Corporation

図表

List of Figures

Figure 1: Global: Proteomics Market: Major Drivers and Challenges
Figure 2: Global: Proteomics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Proteomics Market: Breakup by Analysis Type (in %), 2024
Figure 4: Global: Proteomics Market: Breakup by Component Type (in %), 2024
Figure 5: Global: Proteomics Market: Breakup by Technology (in %), 2024
Figure 6: Global: Proteomics Market: Breakup by Application (in %), 2024
Figure 7: Global: Proteomics Market: Breakup by End-User (in %), 2024
Figure 8: Global: Proteomics Market: Breakup by Region (in %), 2024
Figure 9: Global: Proteomics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 10: Global: Proteomics (Structural Proteomics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Proteomics (Structural Proteomics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Proteomics (Functional Proteomics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Proteomics (Functional Proteomics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Proteomics (Protein Expression Proteomics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Proteomics (Protein Expression Proteomics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Proteomics (Core Proteomics Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Proteomics (Core Proteomics Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Proteomics (Bioinformatics Software and Related Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Proteomics (Bioinformatics Software and Related Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Proteomics (Spectroscopy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Proteomics (Spectroscopy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Proteomics (Chromatography) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Proteomics (Chromatography) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Proteomics (Electrophoresis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Proteomics (Electrophoresis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Proteomics (Protein Microarrays) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Proteomics (Protein Microarrays) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Proteomics (X-Ray Crystallography) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Proteomics (X-Ray Crystallography) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Proteomics (Surface Plasmon Resonance) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Proteomics (Surface Plasmon Resonance) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Proteomics (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Proteomics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Proteomics (Protein Expression Profiling) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Proteomics (Protein Expression Profiling) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Proteomics (Proteome Mining) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Proteomics (Proteome Mining) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Proteomics (Post-translational Modifications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Proteomics (Post-translational Modifications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Global: Proteomics (Clinical Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Global: Proteomics (Clinical Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Global: Proteomics (Research Organizations-Drug Discovery) Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Global: Proteomics (Research Organizations-Drug Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Global: Proteomics (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Global: Proteomics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: North America: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: North America: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: United States: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: United States: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Canada: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Canada: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Asia Pacific: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Asia Pacific: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: China: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: China: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Japan: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Japan: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: India: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: India: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: South Korea: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: South Korea: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Australia: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Australia: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Indonesia: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Indonesia: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Others: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Others: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Europe: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Europe: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Germany: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Germany: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: France: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: France: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: United Kingdom: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: United Kingdom: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Italy: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Italy: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Spain: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Spain: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Russia: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Russia: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Others: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Others: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Latin America: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: Latin America: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Brazil: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 87: Brazil: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 88: Mexico: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 89: Mexico: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 90: Others: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 91: Others: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 92: Middle East and Africa: Proteomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 93: Middle East and Africa: Proteomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 94: Global: Proteomics Industry: SWOT Analysis
Figure 95: Global: Proteomics Industry: Value Chain Analysis
Figure 96: Global: Proteomics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Proteomics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Proteomics Market Forecast: Breakup by Analysis Type (in Million USD), 2025-2033
Table 3: Global: Proteomics Market Forecast: Breakup by Component Type (in Million USD), 2025-2033
Table 4: Global: Proteomics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 5: Global: Proteomics Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 6: Global: Proteomics Market Forecast: Breakup by End-User (in Million USD), 2025-2033
Table 7: Global: Proteomics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 8: Global: Proteomics Market Structure
Table 9: Global: Proteomics Market: Key Players

Product Code: SR112025A2156

The global proteomics market size reached USD 41.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 139.4 Billion by 2033, exhibiting a growth rate (CAGR) of 13.68% during 2025-2033. North America currently dominates the market, driven by its robust research infrastructure and strong presence of pharmaceutical and biotech companies. The market is primarily driven by rapid technological advancements in mass spectrometry, increasing incidents of chronic diseases, and rapid shift towards personalized medicines. Moreover, increasing integration of machine learning (ML) and artificial intelligence (AI) are upgrading protein analysis and data interpretation.

Dominant Segments:

Analysis Type: On the basis of analysis type, the market has been segmented into structural proteomics, functional proteomics, and protein expression proteomics.
Component Type: Based on component type, the market has been bifurcated into core proteomics services and bioinformatics software and related services.
Technology: Protein microarrays lead the market as they enable rapid, large-scale analysis of protein interactions, expressions, and functions. Their high-throughput nature makes them ideal for biomarker discovery and disease diagnostics.
Application: On the basis of application, the market has been classified into protein expression profiling, protein mining, and post-translational modifications.
End-User: Research organizations (drug discovery) hold the biggest market share because of their focus on biomarker identification and disease mechanism studies. They are heavily investing in advanced proteomic technologies to accelerate research and development (R&D) activities.
Region: North America leads the proteomics market due to high R&D investments and a large presence of biotech and pharmaceutical companies. Government support, advanced healthcare systems, and early adoption of innovative technologies are further driving market leadership in the region.

Key Players:

The leading companies in proteomics market include Agilent Technologies Inc., Bio-RAD Laboratories Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, GE Healthcare Inc., Horiba Ltd., Luminex Corporation, Merck Group, Perkinelmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

Key Drivers of Market Growth:

Growing Demand for Personalized Medicine: The personalized approach fosters greater adoption of proteomic tools in clinical and pharmaceutical settings. Proteomics identifies specific biomarkers, supporting targeted drug development and improving therapeutic outcomes.
Rising Focus on Cancer Research: Proteins play a crucial role in tumor biology, progression, and drug resistance. Proteomic analysis helps identify cancer-specific biomarkers, supports early diagnosis, and guides targeted therapy. This research demand is enhancing investments in proteomic technologies across oncology studies.
Collaborations Between Academic Institutes and Biotech Companies: Partnerships are facilitating faster development of proteomic tools, diagnostic solutions, and therapeutics. Joint efforts also attract more funding, expand research capacity, and strengthen commercialization pipelines.
Emergence of Single-Cell Proteomics: The development of single-cell proteomics is allowing researchers to study protein expression at the individual cell level. This innovation reveals cellular diversity and rare populations, enhancing disease understanding and drug targeting.
Technological Advancements in Next-Generation Sequencing (NGS): Advancements in next-generation sequencing are enabling multi-omics approaches. NGS data provides genomic context for protein expression studies, improving biomarker discovery and precision medicine.

Future Outlook:

Strong Growth Outlook: The proteomics market is expected to see sustained expansion, due to high demand for personalized medicine and innovations in mass spectrometry and bioinformatics. Ongoing research in drug discovery and biomarker identification is further supporting the market expansion.
Market Evolution: The sector is anticipated to shift from basic protein analysis to advanced techniques like protein microarrays and bioinformatics tools. It is playing a significant role in diagnostics and personalized medicine, reflecting a shift towards more targeted and data-based biological investigations.

The proteomics market is expanding due to the rise of single-cell proteomics, which offers deep insights into cellular heterogeneity, enabling more accurate disease modeling and therapeutic targeting. Collaborations between academic institutions and biotech companies are accelerating innovations, allowing quicker translation of research into practical diagnostic and therapeutic solutions. Technological advancements in mass spectrometry, protein microarrays, and NGS are also enhancing data accuracy, throughput, and cost-efficiency. Improved automation and miniaturization of proteomics instruments are refining efficiency, reducing sample volumes, and lowering operational costs. Moreover, the integration of proteomics with other omics platforms like genomics and metabolomics is enabling comprehensive biological analysis, further broadening its applications. Government funding, regulatory support for biomarker discovery, and increasing utilization of proteomics in agriculture and environmental monitoring are also contributing to the market growth.

Proteomics Market Trends:

Growing incidence of chronic and infectious diseases

High incidence of chronic and infectious ailments is significantly fueling the growth of the market. As conditions like cancer, diabetes, cardiovascular disorders, and infectious diseases are becoming more widespread, there is a rising need to understand disease mechanisms at the molecular level. As per the NIH, in 2024, it was anticipated that there would be 2,001,140 new cancer cases in the United States. Proteomics enables researchers and clinicians to identify disease-specific biomarkers, monitor disease progression, and develop targeted therapies. It also aids in early diagnosis, which is critical in managing chronic illnesses effectively. The demand for personalized medicine and precision treatment is further promoting the use of proteomics tools, as they allow a deeper analysis of protein interactions and functions.

Increasing pharmaceutical R&D activities

The growing pharmaceutical R&D activities are positively influencing the market. As stated in the Swiss Biotech Report 2025, R&D expenditure in Switzerland amounted to SFr2.6 Billion (USD 3.16 Billion) in 2024, with SFr1.4 Billion contributed by private companies. As pharmaceutical companies are wagering on drug discovery and development, there is a rising demand for advanced tools that can offer insights into protein structures, functions, and interactions. Proteomics enables researchers to identify and validate potential drug targets, understand disease pathways, and assess drug efficacy and toxicity at the molecular level. With a strong focus on developing targeted therapies, proteomics is becoming essential for detecting disease-specific biomarkers and tailoring treatments accordingly. Additionally, the adoption of biologics and biosimilars has further intensified the need for precise protein analysis.

Rising AI adoption

Increasing AI adoption is streamlining data analysis, improving pattern recognition, and accelerating biomarker discovery. As per the IMARC Group, the global AI market size was valued at USD 115.62 Billion in 2024. Proteomics generates massive, complex datasets that require advanced computational tools for accurate interpretation. AI algorithms, particularly ML, help identify subtle protein expression patterns linked to specific diseases, enabling faster and more precise diagnostics and drug development. AI also enhances predictive modeling in personalized medicine by integrating proteomic data with other biological datasets. This technological synergy reduces research timelines and boosts efficiency in both academic and pharmaceutical research. Furthermore, AI-oriented automation minimizes human error and lowers operational costs. As organizations are integrating AI into their proteomics workflows, innovations in disease detection and treatment continue to advance rapidly. According to the proteomics market report, this technological trend plays an important role in shaping the future of the industry.

Key Growth Drivers of Proteomics Market:

Partnerships between academic institutes and biotech companies

Increasing alliances between academic institutes and biotech companies are significantly bolstering the proteomics market growth by combining research innovations with commercial execution. Academic institutions offer deep scientific knowledge and cutting-edge discoveries, while biotech firms provide resources, infrastructure, and expertise to translate these findings into market-ready applications. Such partnerships accelerate the development of novel proteomic technologies, diagnostic tools, and therapeutics. Joint ventures help bridge the gap between basic research and real-world clinical needs, leading to faster innovation cycles. These collaborations often attract funding from both public and private sectors, enabling large-scale proteomic studies and advanced biomarker identification. The shared access to talent, equipment, and databases is further strengthening research output and commercial potential.

Emergence of single-cell proteomics

The emergence of single-cell proteomics is allowing researchers to analyze proteins at an individual cell level, offering insights into cellular heterogeneity and disease mechanisms. Unlike bulk analysis, which averages signals from numerous cells, single-cell techniques capture the unique proteomic profile of each cell, enabling deeper understanding of cell behavior, immune responses, and cancer progression. This level of granularity is crucial for developing personalized medicine, as it helps identify rare cell types or subpopulations involved in disease. The growing utilization of high-resolution mass spectrometry and microfluidic platforms has made single-cell proteomics more feasible and scalable. As researchers and pharmaceutical companies are adopting this approach, it is opening new avenues for biomarker discovery and therapeutic targeting.

Technological advancements in NGS

Technological advancements in NGS are enhancing multi-omics integration and expanding the depth of biological insights. While NGS is primarily used for genomic and transcriptomic analysis, its synergy with proteomics allows a more complete understanding of cellular function. Researchers can correlate gene expression data with protein expression and modifications, leading to improved biomarker identification and disease modeling. Innovations, such as single-cell sequencing and spatial transcriptomics, are enabling high-resolution mapping of gene and protein networks within tissues. These technologies make it easier to design proteomic experiments informed by genomic context, enhancing accuracy and relevance. The widespread availability of NGS also fosters data-driven research strategies, driving the demand for complementary proteomics tools. As NGS platforms are evolving, they continue to support and broaden applications in the proteomics market.

Proteomics Market Segmentation:

Breakup by Analysis Type:

Structural Proteomics
Functional Proteomics
Protein Expression Proteomics

Structural proteomics is concerned with detailed analysis of protein interactions, structures, and functions. This field is required for studying disease mechanism and drug development. Advanced instruments and techniques boost growth, facilitating high-resolution structural comprehensions. Leading research institutions and companies are globally investing in structural proteomics to develop innovative therapeutic solutions.

Functional proteomics emphasizes on recognizing protein interactions and functions within a biological context. This discipline leverages advanced techniques to examine the dynamics of protein modifications, activities, and networks. In the global proteomics market, functional proteomics plays a crucial role by spurring innovations in personalized medicine, drug discovery, and disease diagnostics. By offering discernments into protein pathways and mechanisms, it encourages the development of targeted therapies and biomarker identification, substantially improving the efficacy and accuracy of medical treatments.

Protein expression proteomics examines the qualitative and quantitative aspects of protein formation within cells. It includes high-throughput techniques to compare and profile protein expression levels across various treatments or conditions. In the global proteomics market outlook, this subfield is pivotal for comprehending disease mechanisms, identifying biomarkers, and innovating novel therapeutic strategies. The proficiency of monitoring protein expression changes in response to numerous stimuli facilitates the development of enhanced and effective personalized medical initiatives and early detection of diseases.

Breakup by Component Type:

Core Proteomics Services
Bioinformatics Software and Related Services

Core proteomics services include the protein identification, quantification, and analysis by leveraging advanced techniques such as chromatography and mass spectrometry. These services permit researchers to interpret complex protein interactions and functions, streamlining discoveries in therapeutic targets, disease mechanisms, and biomarker identification. Specialization in data acquisition, interpretation, and sample preparation is crucial for accurate results.

Bioinformatics software and related services provide crucial tools for data visualization and analysis. These services feature algorithms for protein structural prediction, sequence alignment, and functional annotation. Incorporating bioinformatics with proteomics propels research by reconfiguring raw data into meaningful biological insights, endorsing advancements in drug development and personalized medicine. For instance, in October 2023, Ionpath, a high-definition spatial proteomics developer, launched user-friendly bioinformatics tools named MIBIplus and MIBIsight that offers controlled data interpretation by using mass spectrometry to study various proteins associated with immune-oncology.

Breakup by Technology:

Spectroscopy
Chromatography
Electrophoresis
Protein Microarrays
X-Ray Crystallography
Surface Plasmon Resonance
Others

Protein microarrays represent the leading market segment

Protein microarrays demonstrate a high-throughput platform in proteomics market, allowing simultaneous analysis of numerous protein samples. By immobilizing proteins on solid surfaces, these arrays foster rapid quantification and detection, promoting therapeutic development, biomarker discovery and diagnostics within the global proteomics market. For instance, in February 2024, Infinity Bio launched new technology, based on MIPSA technology, that leverages protein microarray method to analyze antibody-antigen binding. Maryland-based PTX Capital and Blackbird BioVentures granted USD 4 million fund to Infinity for the development of this technology, allowing the production of large arrays of proteins or peptides in a highly programmed manner. It also aids in combining full-length proteins and peptides in a single reaction, which allows researchers to study antibodies interaction with the 3D structure of full proteins and collect information on the specific peptide sequences that function as antibody epitopes.

Breakup by Application:

Protein Expression Profiling
Proteome Mining
Post-translational Modifications

Protein expression profiling is a pivotal technique permitting the quantification and identification of proteins within a specific biological sample. This process offers valuable analysis of disease mechanisms and cellular functions, promoting the development of personalized medicine and targeted therapeutics by locating specific protein markers associated with numerous conditions.

Proteome mining is an inclusive approach that encompasses the systematic assessment of the entire proteome to discover novel proteins and apprehend their functions. This method propels advancements in drug development and biomarker discovery, presenting an in-depth understanding of potential therapeutic targets and biological processes for numerous diseases.

Post-translational modification (PTM) analysis targets the chemical modifications post the synthesis of proteins. These modifications greatly influence protein stability, function, and interactions. In the global proteomics market, PTM analysis aids in elucidating complex regulatory mechanisms, promoting the development of innovative diagnostics and treatments.

Breakup by End-User:

Clinical Diagnostic Laboratories
Research Organizations (Drug Discovery)
Others

Research organizations dominate the market

By utilizing proteomic data, research organizations uncover new drug targets, expound disease mechanisms, and boost the development of effective treatments, consequently spurring advancements in biotechnological and pharmaceutical sectors. For instance, in July 2024, Olink Holding AB, a leading proteomics company, launched its network of Olink Certified Service Providers that will represent service labs and contract research organization (CROs) worldwide.

Breakup by Region:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America leads the market, accounting for the largest proteomics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market, holding the largest share of the proteomics market revenue.

The market in North America is undergoing notable growth, principally driven by significant investments in research and development, and upgraded healthcare infrastructure. Furthermore, the increasing incidents of chronic diseases and intensifying focus on personalized medicine is boosting the market growth. In additional, robust support by government and funding initiatives escalate the utilization of proteomics technology in academic and clinical research. For instance, in September 2023, Multiomics CRO Psomagen launched its Spatial Biology services for 10X Genomics Xenium in North America. Psomagen's Xenium Service integrates various omics platforms, including proteomics, genomics, and transcriptomics.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the proteomics industry include Agilent Technologies Inc., Bio-RAD Laboratories Inc., Bruker Corporation, Creative Proteomics, Danaher Corporation, GE Healthcare Inc., Horiba Ltd., Luminex Corporation, Merck Group, Perkinelmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The competitive landscape of the global proteomics market is represented by the presence of major companies that are actively competing to strengthen their market position through strategic collaborations and technological advancements. For instance, in April 2024, Biognosys and Alamar Biosciences announced that they have entered into a strategic partnership for joint scientific research in biofluid-based proteomics. This partnership brings together Biognosys' expertise in data independent acquisition mass spectrometry (DIA-MS) and Alamar's cutting-edge immunoassays. Market players are currently emphasizing on research and development investment and expansion of their product portfolios to lead this swiftly evolving sector. Acquisitions and mergers are also common, aimed at unifying resources and expertise. The market is currently experiencing intense competition, fueled by escalating demand for advanced diagnostic tools and precision medicine, mandating continuous innovation.

Key Questions Answered in This Report

1.How big is the global proteomics market?
2.What is the expected growth rate of the global proteomics market during 2025-2033?
3.What are the key factors driving the global proteomics market?
4.What has been the impact of COVID-19 on the global proteomics market?
5.What is the breakup of the global proteomics market based on the technology?
6.What is the breakup of the global proteomics market based on the end-user?
7.What are the key regions in the global proteomics market?
8.Who are the key players/companies in the global proteomics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Proteomics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Analysis Type

6.1 Structural Proteomics
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Functional Proteomics
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Protein Expression Proteomics
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Component Type

7.1 Core Proteomics Services
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Bioinformatics Software and Related Services
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Technology

8.1 Spectroscopy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Chromatography
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Electrophoresis
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Protein Microarrays
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 X-Ray Crystallography
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Surface Plasmon Resonance
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
8.7 Others
- 8.7.1 Market Trends
- 8.7.2 Market Forecast

9 Market Breakup by Application

9.1 Protein Expression Profiling
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Proteome Mining
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Post-translational Modifications
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by End-User

10.1 Clinical Diagnostic Laboratories
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Research Organizations (Drug Discovery)
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Others
- 10.3.1 Market Trends
- 10.3.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Agilent Technologies Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Bio-RAD Laboratories Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Bruker Corporation
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Creative Proteomics
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 Danaher Corporation
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 GE Healthcare Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Horiba Ltd.
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
- 15.3.8 Luminex Corporation
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Merck Group
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Perkinelmer Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Promega Corporation
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
- 15.3.12 Thermo Fisher Scientific Inc.
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio
  - 15.3.12.3 Financials
  - 15.3.12.4 SWOT Analysis
- 15.3.13 Waters Corporation
  - 15.3.13.1 Company Overview
  - 15.3.13.2 Product Portfolio
  - 15.3.13.3 Financials
  - 15.3.13.4 SWOT Analysis

プロテオミクスの市場レポート：分析タイプ別、コンポーネントタイプ別、技術別、用途別、エンドユーザー別、地域別、2025～2033年

Proteomics Market Report by Analysis Type, Component Type, Technology, Application, End-User (Clinical Diagnostic Laboratories, Research Organizations, and Others), and Region 2025-2033

主要セグメント

主要プレイヤー

主な市場促進要因

将来の展望

プロテオミクス市場の動向

プロテオミクス市場の主な成長要因

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のプロテオミクス市場

第6章 市場内訳：分析タイプ別

第7章 市場内訳：コンポーネントタイプ別

第8章 市場内訳：技術別

第9章 市場内訳：用途別

第10章 市場内訳：エンドユーザー別

第11章 市場内訳：地域別